Earnings History Data for Kaleido Biosciences, Inc. (KLDO) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Kaleido Biosciences, Inc.

Kaleido Biosciences Inc. is a clinical-stage healthcare company. It focuses on leveraging the potential of the microbiome organ to treat disease and improve human health. The Company's product candidates are Microbiome Metabolic Therapies(TM), which are designed to modulate the metabolic output and profile of the microbiome by driving the function and distribution of the organ's existing microbes. Kaleido Biosciences Inc. is based in Lexington, Massachusetts.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
11-08-2021	PM	7:30 AM ET (Aug 11)	KLDO	Kaleido Biosciences, Inc.	251.71	-0.56	-0.59	-0.59	Kaleido Biosciences EPS beats by $0.01, beats on revenue [8/11/2021 7:49 AM]	6.23	0.23 (3.83%)	6.15	0.15 (2.50%)	5.04 - 20.50	100,243	110,000	872
Kaleido Biosciences and COPD Foundation ink strategic collaboration to study KB109 [8/10/2021 7:45 AM] Kaleido Biosciences EPS beats by $0.01, beats on revenue [8/11/2021 7:49 AM] Kaleido Biosciences Announces New Chairperson Appointment to its Board of Directors [Aug-09-21 04:15PM] Kaleido Biosciences and the COPD Foundation Announce a Strategic Collaboration to Advance KB109 into Phase 2 Clinical Trial [Aug-10-21 07:30AM] Kaleido Biosciences Reports Second Quarter 2021 Financial Results [Aug-11-21 07:30AM] Kaleido Biosciences, Inc. (KLDO) Reports Q2 Loss, Lags Revenue Estimates [Aug-11-21 08:55AM]
04-05-2021	PM		KLDO	Kaleido Biosciences, Inc.	335.00	-0.58	-0.64	0.00	Kaleido Biosciences EPS misses by $0.01 [5/4/2021 8:13 AM]	7.11	-0.25 (-3.40%)	7.11	0.0 (0.00%)	5.04 - 20.50	177,818	280,000	182
Kaleido Biosciences EPS misses by $0.01 [5/4/2021 8:13 AM] Kaleido Biosciences Reports First Quarter 2021 Financial Results [May-04-21 07:30AM]
03-03-2021	PM		KLDO	Kaleido Biosciences, Inc.	353.00	-0.56	-0.41	0.00	Kaleido Biosciences EPS beats by $0.11 [3/3/2021 7:54 AM]	9.82	0.24 (2.51%)	9.58	0.0 (0.00%)	2.82 - 20.50	164,472	233,045	110
Kaleido Biosciences EPS beats by $0.11 [3/3/2021 7:54 AM] Kaleido Biosciences Reports Fourth Quarter and Full Year 2020 Financial Results [Mar-03-21 07:35AM]
04-08-2020	PM		KLDO	Kaleido Biosciences, Inc.	225.08	-0.59	0.00	-0.83	Kaleido Biosciences EPS misses by $0.03 [8/4/2020 7:48 AM]	6.67	0.08 (1.21%)	6.50	-0.08 (-1.22%)	2.82 - 10.36	31,067	123,092	2,044

14-05-2020	PM	7:35 AM ET (May 14)	KLDO	Kaleido Biosciences, Inc.	201.24	-0.64	-0.65	-1.56	Kaleido Biosciences EPS in-line [5/14/2020 6:39 AM]	6.50	0.70 (12.07%)	6.51	0.09 (1.40%)	2.82 - 19.00	119,302	102,863	627